Nuveen’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.3B Buy
12,978,519
+488,064
+4% +$114M 0.79% 19
2026
Q1
$3.05B Buy
12,490,455
+1,881,284
+18% +$438M 0.83% 16
2025
Q4
$2.2B Buy
10,609,171
+683,967
+7% +$135M 0.57% 19
2025
Q3
$1.84B Buy
9,925,204
+938,711
+10% +$161M 0.49% 29
2025
Q2
$1.37B Buy
8,986,493
+730,414
+9% +$112M 0.38% 41
2025
Q1
$1.37B Sell
8,256,079
-460,298
-5% -$72M 0.42% 40
2024
Q4
$1.26B Sell
8,716,377
-454,728
-5% -$70.5M 0.36% 43
2024
Q3
$1.49B Buy
9,171,105
+115,161
+1% +$18.3M 0.42% 36
2024
Q2
$1.32B Sell
9,055,944
-220,831
-2% -$32.8M 0.39% 42
2024
Q1
$1.47B Sell
9,276,775
-142,970
-2% -$22.8M 0.44% 37
2023
Q4
$1.48B Sell
9,419,745
-15,143
-0.2% -$2.32M 0.47% 32
2023
Q3
$1.47B Sell
9,434,888
-1,251,625
-12% -$207M 0.52% 30
2023
Q2
$1.77B Sell
10,686,513
-201,794
-2% -$32.6M 0.62% 24
2023
Q1
$1.69B Sell
10,888,307
-31,613
-0.3% -$5.1M 0.63% 27
2022
Q4
$1.93B Sell
10,919,920
-794,610
-7% -$137M 0.75% 19
2022
Q3
$1.91B Sell
11,714,530
-661,110
-5% -$112M 0.78% 14
2022
Q2
$2.2B Buy
12,375,640
+298,259
+2% +$53.1M 0.85% 14
2022
Q1
$2.12B Buy
12,077,381
+1,253,500
+12% +$213M 0.69% 21
2021
Q4
$1.85B Sell
10,823,881
-681,398
-6% -$112M 0.55% 33
2021
Q3
$1.86B Sell
11,505,279
-2,303,606
-17% -$393M 0.57% 25
2021
Q2
$2.27B Sell
13,808,885
-586,665
-4% -$97.1M 0.68% 18
2021
Q1
$2.37B Buy
14,395,550
+119,687
+0.8% +$19.4M 0.75% 15
2020
Q4
$2.25B Sell
14,275,863
-44,253
-0.3% -$6.53M 0.76% 15
2020
Q3
$2.13B Sell
14,320,116
-1,020,095
-7% -$151M 0.82% 15
2020
Q2
$2.16B Sell
15,340,211
-453,360
-3% -$66.1M 0.88% 13
2020
Q1
$2.07B Sell
15,793,571
-462,644
-3% -$65.6M 1.01% 10
2019
Q4
$2.37B Sell
16,256,215
-776,818
-5% -$105M 0.9% 11
2019
Q3
$2.2B Buy
17,033,033
+108,377
+0.6% +$14.3M 0.89% 12
2019
Q2
$2.36B Buy
16,924,656
+16,619,550
+5,447% +$2.3B 0.93% 11
2019
Q1
$42.7M Sell
305,106
-13,989
-4% -$1.87M 0.23% 93
2018
Q4
$41.2M Buy
319,095
+14,235
+5% +$1.99M 0.26% 78
2018
Q3
$42.1M Buy
304,860
+6,785
+2% +$902K 0.22% 117
2018
Q2
$36.2M Sell
298,075
-22,281
-7% -$2.78M 0.23% 122
2018
Q1
$41.1M Sell
320,356
-11,028
-3% -$1.49M 0.27% 95
2017
Q4
$46.3M Sell
331,384
-3,526
-1% -$491K 0.3% 81
2017
Q3
$43.5M Sell
334,910
-7,928
-2% -$1.05M 0.28% 84
2017
Q2
$45.4M Sell
342,838
-159,132
-32% -$20.3M 0.29% 77
2017
Q1
$62.5M Sell
501,970
-387,789
-44% -$46.3M 0.37% 55
2016
Q4
$103M Buy
889,759
+191,144
+27% +$22.1M 0.52% 31
2016
Q3
$82.5M Sell
698,615
-37,079
-5% -$4.5M 0.48% 39
2016
Q2
$89.2M Sell
735,694
-64,159
-8% -$7.29M 0.55% 36
2016
Q1
$86.5K Sell
799,853
-877
-0.1% -$90.8K 0.45% 34
2015
Q4
$82.3K Sell
800,730
-18,585
-2% -$1.87M 0.42% 36
2015
Q3
$76.5K Sell
819,315
-51,680
-6% -$5M 0.43% 33
2015
Q2
$84.9K Sell
870,995
-14,311
-2% -$1.43M 0.46% 32
2015
Q1
$89.1M Buy
885,306
+44,650
+5% +$4.54M 0.49% 30
2014
Q4
$87.9M Buy
840,656
+34,836
+4% +$3.67M 0.49% 34
2014
Q3
$85.9M Buy
805,820
+1,578
+0.2% +$164K 0.53% 31
2014
Q2
$84.1M Sell
804,242
-7,979
-1% -$806K 0.51% 29
2014
Q1
$79.8M Sell
812,221
-7,978
-1% -$740K 0.48% 36
2013
Q4
$75.1M Sell
820,199
-6,322
-0.8% -$583K 0.48% 32
2013
Q3
$71.7M Sell
826,521
-47,669
-5% -$4.28M 0.46% 35
2013
Q2
$75.1M Buy
+874,190
New +$74.2M 0.5% 33

Other funds holding JNJ

Nuveen's JNJ Position: Q2 2026 in Review

Nuveen increased its Johnson & Johnson (JNJ) stake by 3.9% in Q2 2026, buying an estimated $114M and bringing the position to 12,978,519 shares worth $3.3B. The position accounts for 0.79% of the portfolio, ranked #19.

Nuveen first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Nuveen held 12,978,519 shares of Johnson & Johnson worth $3.3B as of Q2 2026.
  • Nuveen bought 488,064 Johnson & Johnson shares in Q2 2026, an estimated $114M.
  • Johnson & Johnson made up 0.79% of Nuveen's portfolio in Q2 2026, its #19 holding.
  • Nuveen first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.